Ditropan XL (Oxybutynin Chloride Extended Release Tablets) Drug Information: Medication Guide and Patient Information

Pill Identifier Search

May 27, 2012

Ditropan XL

Urinary Incontinence in Children »

Urinary incontinence in children facts

Urinary incontinence in children is very common.
Nighttime wetting (nocturnal enuresis) is more common than daytime wetting (diurnal enuresis).
Most urinary incontinence is nonorganic and resolves without intervention.
Persistent primary enuresis and secondary enuresis may require further medical evaluation.
Treatment for most cases of enuresis involves behavioral modification.
Bedwetting alarms are very effective.
Medications should be reserved for select children.
Less than 1% of all affected children have persistent incontinence into adulthood.

What is urinary incontinence?

Very simply stated, urinary incontinence is defined as the loss of complete control of the act of urination or the involuntary emptying of the bladder. It is also referred to as enuresis. It can be caused by any number of factors,...

Read the Urinary Incontinence in Children article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Ditropan XL User Reviews >>

Ditropan XL

Urinary Incontinence in Women Slideshow Pictures

Urinary Incontinence in Men Slideshow Pictures

Food & Drinks That Make You Gotta Go Slideshow Pictures

font size

PATIENT INFORMATION

Patients should be informed that oxybutynin may produce angioedema that could result in life-threatening airway obstruction. Patients should be advised to promptly discontinue oxybutynin therapy and seek immediate medical attention if they experience edema of the tongue, edema of the laryngopharynx, or difficulty breathing.

Patients should be informed that heat prostration (fever and heat stroke due to decreased sweating) can occur when anticholinergics such as oxybutynin chloride are administered in the presence of high environmental temperature.

Because anticholinergic agents such as oxybutynin may produce drowsiness (somnolence) or blurred vision, patients should be advised to exercise caution.

Patients should be informed that alcohol may enhance the drowsiness caused by anticholinergic agents such as oxybutynin.

Patients should be informed that DITROPAN XL® should be swallowed whole with the aid of liquids. Patients should not chew, divide, or crush tablets. The medication is contained within a nonabsorbable shell designed to release the drug at a controlled rate. The tablet shell is eliminated from the body; patients should not be concerned if they occasionally notice in their stool something that looks like a tablet.

DITROPAN XL® should be taken at approximately the same time each day.

Last reviewed on RxList: 1/5/2012
This monograph has been modified to include the generic and brand name in many instances.